Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized
Sivanathan S
Casein kinase Iepsilon (CKIepsilon) is an essential component of the biological clock
It can inhibit ULK in vitro and block autophagy in cells
UNC0638 - G9a HMTase Inhibitor. CAS# 1255580-76-7 0332 Veliparib in combination with whole-brainUNC0638, CAS No. 1255580 76 7, is a potent, selective and cell permeable G9a and GLP inhibitor, with a toxicity function ratio of >100, compared to <6 for BIX01294. UNC0638 inhibits G9a HMTase with an IC50 ~15 nM and GLP, a closely related H3K9 HMTase, with an IC50~19 nM, but is more than 10, 000 fold selective over other epigenetic targets. G9a (EHMT2) and GLP (EHMT1) catalyze the mono and dimethylation of lysine 9 of histone 3 (H3K9) and other non
US$ 134.99
US$ 24.99
US$ 15.99